Q2 Earnings Forecast for ITOS Issued By Leerink Partnrs
iTeos Therapeutics, Inc. (NASDAQ:ITOS – Free Report) – Investment analysts at Leerink Partnrs issued their Q2 2025 earnings per share (EPS) estimates for shares of iTeos Therapeutics in a report issued on Wednesday, May 14th. Leerink Partnrs analyst D. Graybosch expects that the company will post earnings of ($0.62) per share for the quarter. Leerink […]
